论文部分内容阅读
作者在尼日利亚伊巴丹用氯喹和长效磺胺-乙胺嘧啶合剂(法西达),对确诊患恶性疟的58例(9个月～10岁)的非州儿童进行治疗。其中不包括严重病例或并发有胃肠炎,支气管肺炎和麻疹病等的患者。观察对象随机分为甲、乙两组。甲组28人,接受氯喹25mg/kg分3次服。第1,2天各服10mg/kg,第3天服5mg/kg。乙组30人,接受法西达治疗,顿服一剂。剂量为长效磺胺35mg/kg合并1/20的乙胺嘧啶(1.25mg/kg)。两组均于治疗开始的第一周每天给服阿斯匹林,并在观察期间给予复方维生素B。
The authors treated 58 children (9 months to 10 years) of non-state children diagnosed with falciparum malaria with chloroquine and the long-acting sulfonamide-pyrimethamine mixture (Faridabal) in Ibadan, Nigeria. This does not include severe cases or patients with gastroenteritis, bronchopneumonia and measles. Subjects were randomly divided into A and B groups. A group of 28 people, to accept chloroquine 25mg / kg points 3 times service. The first and second days of each service 10mg / kg, the first 3 days of service 5mg / kg. Group B 30, receiving Faxida treatment, Dayton served one. The dose of long-acting sulfonamide 35mg / kg with 1/20 pyrimethamine (1.25mg / kg). Both groups received aspirin once daily during the first week of treatment and were given compound vitamin B during the observation period.